155 related articles for article (PubMed ID: 10694924)
21. Y-position cysteine substitution in type I collagen (alpha1(I) R888C/p.R1066C) is associated with osteogenesis imperfecta/Ehlers-Danlos syndrome phenotype.
Cabral WA; Makareeva E; Letocha AD; Scribanu N; Fertala A; Steplewski A; Keene DR; Persikov AV; Leikin S; Marini JC
Hum Mutat; 2007 Apr; 28(4):396-405. PubMed ID: 17206620
[TBL] [Abstract][Full Text] [Related]
22. Splice site mutation causing deletion of exon 21 sequences from the pro alpha 2(I) chain of type I collagen in a patient with severe dentinogenesis imperfecta but very mild osteogenesis imperfecta.
Nicholls AC; Oliver J; McCarron S; Winter GB; Pope FM
Hum Mutat; 1996; 7(3):219-27. PubMed ID: 8829655
[TBL] [Abstract][Full Text] [Related]
23. Two alternative exons can result from activation of the cryptic splice acceptor site deep within intron 2 of the dystrophin gene in a patient with as yet asymptomatic dystrophinopathy.
Yagi M; Takeshima Y; Wada H; Nakamura H; Matsuo M
Hum Genet; 2003 Feb; 112(2):164-70. PubMed ID: 12522557
[TBL] [Abstract][Full Text] [Related]
24. A base substitution at the splice acceptor site of intron 5 of the COL1A2 gene activates a cryptic splice site within exon 6 and generates abnormal type I procollagen in a patient with Ehlers-Danlos syndrome type VII.
Chiodo AA; Hockey A; Cole WG
J Biol Chem; 1992 Mar; 267(9):6361-9. PubMed ID: 1556139
[TBL] [Abstract][Full Text] [Related]
25. Mutations in the lysyl hydroxylase 1 gene that result in enzyme deficiency and the clinical phenotype of Ehlers-Danlos syndrome type VI.
Yeowell HN; Walker LC
Mol Genet Metab; 2000; 71(1-2):212-24. PubMed ID: 11001813
[TBL] [Abstract][Full Text] [Related]
26. A heterozygous splice site mutation in COL6A1 leading to an in-frame deletion of the alpha1(VI) collagen chain in an italian family affected by bethlem myopathy.
Pepe G; Giusti B; Bertini E; Brunelli T; Saitta B; Comeglio P; Bolognese A; Merlini L; Federici G; Abbate R; Chu ML
Biochem Biophys Res Commun; 1999 May; 258(3):802-7. PubMed ID: 10329467
[TBL] [Abstract][Full Text] [Related]
27. Abnormal type III collagen produced by an exon-17-skipping mutation of the COL3A1 gene in Ehlers-Danlos syndrome type IV is not incorporated into the extracellular matrix.
Chiodo AA; Sillence DO; Cole WG; Bateman JF
Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):939-43. PubMed ID: 7487954
[TBL] [Abstract][Full Text] [Related]
28. [Mutations of genes coding collagen type I--biochemical and clinical effects].
Wieczorek P; Zawierta J; Rzeuski R
Postepy Hig Med Dosw; 2000; 54(1):99-114. PubMed ID: 10803027
[TBL] [Abstract][Full Text] [Related]
29. A novel mutation in the neurofibromatosis type 1 (NF1) gene promotes skipping of two exons by preventing exon definition.
Fang LJ; Simard MJ; Vidaud D; Assouline B; Lemieux B; Vidaud M; Chabot B; Thirion JP
J Mol Biol; 2001 Apr; 307(5):1261-70. PubMed ID: 11292340
[TBL] [Abstract][Full Text] [Related]
30. A point mutation in an intronic branch site results in aberrant splicing of COL5A1 and in Ehlers-Danlos syndrome type II in two British families.
Burrows NP; Nicholls AC; Richards AJ; Luccarini C; Harrison JB; Yates JR; Pope FM
Am J Hum Genet; 1998 Aug; 63(2):390-8. PubMed ID: 9683580
[TBL] [Abstract][Full Text] [Related]
31. A novel SLC12A3 splicing mutation skipping of two exons and preliminary screening for alternative splice variants in human kidney.
Shao L; Liu L; Miao Z; Ren H; Wang W; Lang Y; Yue S; Chen N
Am J Nephrol; 2008; 28(6):900-7. PubMed ID: 18580052
[TBL] [Abstract][Full Text] [Related]
32. Mutational analysis of the lysyl hydroxylase 1 gene (PLOD) in six unrelated patients with Ehlers-Danlos syndrome type VI: prenatal exclusion of this disorder in one family.
Yeowell HN; Walker LC; Farmer B; Heikkinen J; Myllyla R
Hum Mutat; 2000 Jul; 16(1):90. PubMed ID: 10874315
[TBL] [Abstract][Full Text] [Related]
33. A novel arginine-to-cysteine substitution in the triple helical region of the alpha1(I) collagen chain in a family with an osteogenesis imperfecta/Ehlers-Danlos phenotype.
Lund A; Joensen F; Christensen E; Dunø M; Skovby F; Schwartz M
Clin Genet; 2008 Jan; 73(1):97-101. PubMed ID: 18028452
[No Abstract] [Full Text] [Related]
34. Mutational spectrum of type I collagen genes in Korean patients with osteogenesis imperfecta.
Lee KS; Song HR; Cho TJ; Kim HJ; Lee TM; Jin HS; Park HY; Kang S; Jung SC; Koo SK
Hum Mutat; 2006 Jun; 27(6):599. PubMed ID: 16705691
[TBL] [Abstract][Full Text] [Related]
35. Gene symbol: COL1A2. Disease: Ehlers-Danlos syndrome type VIIB.
Giunta C; Steinmann B
Hum Genet; 2008 Jun; 123(5):540. PubMed ID: 20960610
[No Abstract] [Full Text] [Related]
36. Homozygous Gly530Ser substitution in COL5A1 causes mild classical Ehlers-Danlos syndrome.
Giunta C; Nuytinck L; Raghunath M; Hausser I; De Paepe A; Steinmann B
Am J Med Genet; 2002 May; 109(4):284-90. PubMed ID: 11992482
[TBL] [Abstract][Full Text] [Related]
37. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
38. Ehlers-Danlos syndrome type VII: a single base change that causes exon skipping in the type I collagen alpha 2(I) chain.
Nicholls AC; Oliver J; Renouf DV; McPheat J; Palan A; Pope FM
Hum Genet; 1991 Jun; 87(2):193-8. PubMed ID: 1712342
[TBL] [Abstract][Full Text] [Related]
39. Homozygosity for a splice site mutation of the COL1A2 gene yields a non-functional pro(alpha)2(I) chain and an EDS/OI clinical phenotype.
Nicholls AC; Valler D; Wallis S; Pope FM
J Med Genet; 2001 Feb; 38(2):132-6. PubMed ID: 11288717
[No Abstract] [Full Text] [Related]
40. Osteogenesis Imperfecta/Ehlers-Danlos Overlap Syndrome and Neuroblastoma-Case Report and Review of Literature.
Morabito LA; Allegri AEM; Capra AP; Capasso M; Capra V; Garaventa A; Maghnie M; Briuglia S; Wasniewska MG
Genes (Basel); 2022 Mar; 13(4):. PubMed ID: 35456387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
